Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consort Medical Rights Issue 95.14% Taken Up (ALLISS)

Mon, 03rd Nov 2014 08:00

LONDON (Alliance News) - Consort Medical PLC Monday said its rights issue has got acceptances for 95.14% of the new shares on offer, with the rest to be taken up by Investec as the underwriter of the issue.

In a statement, the company said it had received valid acceptances for 17.4 million shares under the five-for-eight rights issue it announced at the end of September.

By Steve McGrath; stevemcgrath@alliancenews.com; @stevemcgrath1

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
9 Feb 2015 06:15

UK Dividends Calendar - Week Ahead

Read more
6 Feb 2015 16:01

UK Dividends Calendar - Week Ahead

Read more
4 Feb 2015 14:35

Sector movers: GSK leads defensive pharma stocks higher

A massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high. Sales, profits and earnings slumped during the fourth quarter of

Read more
4 Feb 2015 08:23

Consort Medical Signs Multi-Year Supply Agreement

Read more
29 Jan 2015 10:53

Consort Medical Invests Further GBP2.2 Million In Atlas Genetics

Read more
15 Jan 2015 06:21

UK Dividends Calendar - Week Ahead

Read more
14 Jan 2015 16:04

UK Dividends Calendar - Week Ahead

Read more
14 Jan 2015 06:15

UK Dividends Calendar - Week Ahead

Read more
13 Jan 2015 16:01

UK Dividends Calendar - Week Ahead

Read more
13 Jan 2015 06:24

UK Dividends Calendar - Week Ahead

Read more
12 Jan 2015 16:24

UK Dividends Calendar - Week Ahead

Read more
12 Jan 2015 06:18

UK Dividends Calendar - Week Ahead

Read more
9 Jan 2015 16:09

UK Dividends Calendar - Week Ahead

Read more
9 Jan 2015 06:20

UK Dividends Calendar - Week Ahead

Read more
4 Dec 2014 08:46

Thursday broker round-up

Aberdeen: Charles Stanley downgrades to 'hold'. Afren: Canaccord reduces target price from 115p to 65p, while staying with its 'speculative buy' recommendation. Amino Technologies: Northland moves target price from 120p to 130p and retains a 'buy' recommendation. Belgravium Technologies: WH Irelan

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.